The metabolism of apolipoproteins B-48 and B-100 (apo B-48 and B-100) in large triglyceride-rich lipoproteins was studied in three adults with familial dysbetalipoproteinemia (F. dys.) and compared to that of normolipidemic subjects. One Caucasian F.
Introduction
Familial dysbetalipoproteinemia (F. dys.)' is a monogenic disorder characterized by accumulation of remnants of triglyceriderich lipoproteins of both intestinal and hepatic origin in blood plasma (1, 2) . Affected homozygotes who are hyperlipidemic (type III hyperlipoproteinemia) exhibit characteristic xanthomatosis and have an increased risk ofpremature atherosclerotic disease (3) . In contrast to normal very low density lipoproteins (VLDL) which have prebeta mobility, the remnant particles in these patients have beta electrophoretic mobility and are enriched with cholesteryl esters (,B-VLDL). Remnant particles are normally removed rapidly into the liver by receptor-mediated endocytosis (4) . Apolipoprotein (apo) E is critical to this process (4) . F. dys. is associated with homozygosity for a particular isoDr. Stalenhoef's present address is Division ofGeneral Internal Medicine, Department of Medicine, St. Radboud University Hospital, Nijmegen, The Netherlands. Address reprint requests to Dr. Havel. A preliminary report of this work has appeared (1984. Circulation. 70:1I-1 19) .
Receivedfor publication 24 form of this protein (apo E-2), which is taken up poorly by the liver (5) and binds poorly to lipoprotein receptors (6) . Rall and his associates have shown that the isoforms of apo E differ by amino acid substitutions in the primary structure ofthe protein (7) . Homozygosity for the form of apo E in which cysteine replaces arginine at residue 158 in the amino acid sequence, designated E-2 (Arg,58 -. Cys), has been found most commonly in patients with F. dys. and is associated with grossly defective binding to lipoprotein receptors. The defective binding of apo E-2-containing lipoproteins to cellular receptors is thought to be responsible for the accumulation of f3-VLDL, but because homozygosity for apo E-2 isoforms is often observed in the absence of hyperlipoproteinemia (8) , additional genetic or environmental determinants are evidently required for the appearance of hyperlipoproteinemia. Two additional E-2 mutants, E-2 (Arg145 --Cys) and E-2 (Lys,46 -Gln), bind to LDL receptors on human fibroblast receptors with about one-half of the normal affinity but are associated with classical F. dys. (9, 10) . From measurements of the rate of clearance of retinyl esters contained in chylomicrons, it has been concluded that chylomicron remnants are cleared poorly from the blood of subjects with F. dys. (1 1). Retinyl esters, like the other core lipid constituents ofchylomicrons, can be transferred to other lipoproteins by an exchange protein, making them an uncertain marker of particle clearance (12) . Apo B remains with newly secreted triglyceride (TG)-rich lipoprotein particles until they are cleared from the blood (4). We have used a recently described method (13) to study the metabolism of two species of apo B (apo B-48 and apo B-100) in TG-rich lipoproteins in F. dys. subjects possessing two different forms of apo E-2. These two apo Bs are thought to be synthesized primarily in the intestine and liver, respectively, and therefore reflect directly the metabolism of TGrich lipoproteins originating in these organs (14) . We prepared radioiodinated TG-rich lipoproteins containing apo B-48 and apo B-100 from a subject with familial lipoprotein lipase deficiency, a condition in which these lipoproteins are not normally degraded to remnant particles. These lipoproteins were injected intravenously and the rate of removal ofthese two forms of apo B from the blood and the extent of their appearance in lipoproteins of higher density were determined. In our earlier studies using this approach, we showed that both forms of apo B are rapidly removed from the blood of normolipidemic subjects; neither was converted to apo B of low density lipoproteins (LDL) (13). We performed all procedures under sterile conditions as described (13). 4 h after the lipoprotein lipase-deficient donor, J.C. (phenotype E4/2), received a meal of 100 g olive oil dispersed in milk, -300 ml ofblood was obtained by venipuncture, mixed with 1 mg EDTA/ml and centrifuged at 1,000 g for 20 min at room temperature to separate formed elements. The postprandial plasma TG concentration of the donor was 1,300 mg/dl and total plasma cholesterol concentration was 239 mg/dl. 3 ml ofplasma were overlayered with 0.15 M NaCl/l mM EDTA, pH 7.4, in each of 54 polyallomer centrifuge tubes, and centrifuged in 40.3 rotors of Beckman ultracentrifiges (Beckman Instruments, Inc., Palo Alto, CA) at 250C
for 30 min at 30,000 rpm. The TG-rich particles were recovered in the top 0.75 ml. To facilitate layering with the salt solution, the density of the isolated material was increased by addition of 0.50 volume of 2H20 containing 1 mM EDTA. Centrifuigation was then repeated under the same conditions. The TG-rich particles were labeled with '"I by the iodine monochloride method (16) . Unreacted iodine was removed by dialysis against 0.15 M NaCl/l mM EDTA, pH 7.4 and Rexyn 1-300 (Fisher Scientific Corp., Springfield, NJ) for 2 h at 4VC and then for 24 h in the absence of Rexyn with several changes of dialysis liquid. In previous experiments (13) we incubated the labeled TG-rich lipoproteins with the recipient's plasma and reisolated them before injection in order to exchange labeled proteins other than apo B with their counterparts in high density lipoproteins. We omitted this step in the current study because the reduction of'251 in proteins other than apo B (mainly C apoproteins) was small. Apo E ofthe recipients also exchanged with that of the donor during these incubations, as shown by alteration ofthe isoform pattern of apo E. For example, incubation with plasma of M.B. (phenotype E3/3) increased the E3 component of the TG-rich lipoproteins of donor J.C. (phenotype E4/2). Tests were performed for the presence ofendotoxins (Pyrogent, Mallinckrodt, St. Louis, MO) and portions were taken for culture ofbacteria. We injected the labeled TG-rich lipoproteins (-50 4Ci) about 60 h after the donor was bled. The total amount of TG injected into each subject was 12.3 mg and the amount of protein injected was 0.6 mg. Fractions of the injected TG-rich lipoproteins, differing in size or density, were separated by gel permeation chromatog-raphy (17) and by density gradient ultracentrifugation (18) . To determine the composition of the TG-rich lipoproteins and its fractions, TG (19) , free and esterified cholesterol (20) , phospholipids (21) , and protein (22) were estimated. The TG-rich lipoproteins were further characterized by analytical isoelectric focusing polyacrylamide gel electrophoresis (pH 3.5-7.0) of the component proteins (23) . We separated molecular species of apo B in polyacrylamide gels with a gradient from 2.5 to 27% as described (24) with some modifications (13). The percentage of total 1251 in apo B-100 and B-48 of the injected TG-rich lipoproteins was 7.2 and 4.5%, respectively. The calculated labeling oftotal apo B was 0.4 mol 125I/moi, assuming a molecular mass of 400,000 D. Lipid labeling was 24.7% and 98.8% of the label was precipitated by 10% trichloroacetic acid (TCA). Electron microscopy of the TG-rich lipoproteins and its fractions was performed on samples negatively stained with potassium phosphotungstate (25) . Particle diameters were measured on the photographic prints at a magnification of 180,000 (26) .
Preparation of lipoproteins and isolation of apo B-100 and B-48. After injection of the TG-rich lipoproteins, the recipients were given meals containing <5 g fat (total) for the next 24 h. Blood was collected at intervals into EDTA (1 mg/ml) and chilled on ice. Preparation of the lipoprotein fractions was begun the same day. We separated lipoproteins sequentially by ultracentrifugation of6 ml plasma in 40.3 rotors ofBeckman ultracentrifuges at nonprotein solvent densities of 1.006, 1.019, and 1.063 g/ml (27) . Densities were adjusted to 1.019 g/ml with 2H20 in 0.15 M NaCI and with KBr to 1.063 g/ml. Top fractions were collected in a volume of 1.5 ml. Radioactivity was measured in all fractions in a gamma spectrometer, recovery of total 1251 in the serial samples taken after injection was 91-99% for R.M., 90-103% for R.O., 88-103% for W.McC., and 86-99% for H.S. Correction was made for KBr quenching in the fractions 1.019 < d < 1.063 g/ml and d > 1.063 g/ml.
Apo B-100 and apo B-48 were isolated from the d < 1.006 g/ml fractions by electrophoresis in polyacrylamide gradient gels (13). In this fraction, 91.2-97.7% of 1251I was precipitated by 10% TCA. 50 to 200 Ml (100-300 Mg of protein) were mixed with SDS and sucrose to give final concentrations ofeach of 3%, heated for 30 s in boiling water, and applied to the gels. Electrophoresis was carried out in the presence of reducing agents (1% mercaptoacetic acid and 1% mercaptopropanediol) for 16 h at 2 mA. (These reducing agents were added to prevent disulfide bridging between apo B species. The mercaptoacetic acid purges the gel of persulfate and the mercaptopropanediol remains at the top of the gel where aggregation is likely to occur.) After staining and destaining (13), the gels were sliced into six segments and radioactivity was measured in each segment, including narrow segments of 3 mm that contained apo B-100 and B-48. Electrophoresis was performed in multiple runs when necessary to obtain sufficient protein for measurement of 1251.
The amount of total 1251I-apo B was determined in the lipoprotein fractions 1.006 < d < 1.019 g/ml [intermediate density lipoproteins (IDL)] and 1.019 < d < 1.063 g/ml (LDL) from the difference between 1251 in the total sample and 1251 in the isopropanol-soluble fraction (28) .
Results
Characterization ofthe labeled TG-rich lipoproteins. The labeled lipoprotein preparation was free of endotoxin and was sterile. Its composition and that ofthe three fractions separated by density gradient ultracentrifugation are shown in Table II . The content of all components except triglycerides was directly related to density. The amount of 125I-B-I00 as compared with '25I-B-48 was the lowest in the less dense fractions and fivefold higher in the fraction of highest density. The same patterns were found in five fractions separated by gel permeation chromatography (Table III) . In these fractions the 125I-B-100:25I-B-48 ratio increased from 0.60 to 5.76 with decreasing particle diameter. Particles with diameters greater than 800 A were separated most effectively by ultracentrifugation; those of smaller diameter by gel chromatography. From these data, it can be estimated that lipoproteins of blood plasma of the four normolipidemic subjects during the first 2 h after injection. Data are the same as those shown in Fig. 2 and intestine, respectively (29) . The difference in particle size distribution of labeled apo B-48 and apo B-100 (Tables II and  III) suggests that this is the case for subjects with lipoprotein lipase deficiency as well.
In the normolipidemic, E3/3 subject of the current study, apo B-48 in chylomicrons was removed in a few minutes, and the removal of apo B-100 derived from the large VLDL was only slightly slower. These results are similar to those obtained earlier in normal persons (13); we suggested that the very short residence times for apo B-100 were explained by the nature of the particles injected, i.e., their large size and the fact that they have not been acted upon by lipoprotein lipase. In most studies in which the entire lipoprotein fraction of d < 1.006 g/ml has been labeled (for example, ref. 30), the apo B is contained predominantly in particles that are considerably smaller and contain not only nascent particles but also a variable number of remnants. Furthermore, in this as well as in our earlier study, very little labeled apo B-48 or apo B-I00 was found in lipoproteins of d > 1.006 g/ml of normal persons, indicating that few large nascent VLDL are converted to LDL. Consistent with our findings is a recent report by Packard and associates (31) . These investigators injected VLDL (Sf 100-400) obtained from subjects with endogenous hypertriglyceridemia into normolipidemic subjects. The residence times that they observed for total apo B approach the values found by us, and only a small fraction (-10%) of the apo B associated with these particles was found in LDL. These investigators concluded that a subfraction of VLDL, which is secreted from the liver as small particles, is mainly converted to LDL.
We found that only 70-80% of the apo B-100 and about 60% of apo B-48 was present in the VLDL fraction of plasma of normal subjects 2 min after injection, followed usually by a plateau during the new few minutes (Fig. 3) . Only about 10% of the injected '25I-apo B was recovered in other lipoprotein fractions at this time. We found close to 100% of apo B-100 in the VLDL fraction from 2 to 15 min after injection into two subjects with lipoprotein lipase deficiency (13). Therefore, mixing of the lipoprotein particles in the plasma compartment appears to be essentially complete 2 min after injection. We postulate that the early removal reflects partition of the injected TG-rich lipoproteins onto lipoprotein lipase sites on the capillary endothelium ("margination") and that, following partial lipolysis, the particles are released back into the plasma compartment. In hyperlipemic subjects, such as those with F. dys., the injected particles presumably compete with a larger number of endogenous particles, so that fewer marginate initially. The greater apparent margination of chylomicrons as compared with VLDL can be explained by the higher affinity of the former for the enzyme.
In sharp contrast to their rapid disappearance in the normolipidemic subjects was the slow rate of removal of both apo B-48 and apo B-100 in those with F. dys. This observation, particularly in R.O., Who had normal total plasma lipid levels, is consistent with a profound defect in the hepatic uptake of chylomicron and VLDL remnants in F. dys. The amount ofnormal apo E contained in the injected TG-rich lipoproteins was negligible and presumably exchanged rapidly with that of the recipients. The initial hydrolysis ofTG-rich lipoproteins and consequent formation of remnants is presumably unimpaired in F. dys., because lipoprotein lipase is normal (32, 33) . This conclusion is supported by recent studies of Packard and associates (31) , who injected autologous large TG-rich lipoproteins (Sf 100-400) into three hyperlipidemic F. dys. subjects. (35) . Although direct synthesis of apo B in IDL cannot be excluded as a factor contributing to the accumulation of remnants, these studies did not take into account the structural and metabolic heterogeneity of the precursors of IDL (2, 36) . Other kinetic studies in which the whole VLDL fraction was radiolabeled and injected without differentiating lipoproteins ofdifferent sources also suggested that catabolism ofVLDL is impaired in F. dys. (37, 38) . That a portion of the accumulated remnant particles in F. dys. originated as chylomicrons was suggested earlier from compositional analysis of fractions oftriglyceride-rich lipoproteins (39) before the presence of the intestinal apo B-48 in the fl-VLDL fraction was known (2, 36 ). An abnormality of chylomicron metabolism has been further supported by the retention in VLDL ofretinyl esters which were given with an oral fat load as a marker for particles of dietary origin (11) . In an extension ofthis observation, it was recently reported that the catabolism of chylomicrons labeled with retinyl esters is markedly retarded in normolipidemic E2/2 homozygotes (40) .
The elucidation of the structure of apo E and its role in the uptake of TG-rich lipoproteins by the liver have been of major importance to our understanding of the metabolic defects in F. dys. (5-7) . Apo E exhibits genetically determined polymorphism (8) produced by multiple alleles occurring at a single locus (41) . These alleles are for the structural genes of apo E and specify the apo E proteins that differ by a single amino acid (7, 9, 10) . As compared with normal apo E, the forms of the protein that are associated with F. dys. have reduced affinity for cellular receptors (6) and are removed slowly into perfused rat livers (5) and from the blood of subjects with F. dys. (42) . Three variant apo E-2's are now known (9, 10) . In addition to the common form of apo E-2 in which cysteine replaces arginine at residue 158, designated as apo E-2 (Arg,5g --Cys), cysteine-arginine interchanges have been found at residue 145 in three subjects, apo E-2 (Arg14s --Cys) (9) . All of these subjects are Black; the two who are homozygotes took part in the current study. A new structural variant recently has been reported in one subject with F. dys. with a glutamine for lysine interchange at residue 146 (10) . The binding of these two additional apo E-2 mutants to LDL (apo B-100/E) receptors in vitro was found to be much less defective than that of apo E-2 (Argl58g-. Cys). Nevertheless, the severity of the defect in remnant clearance was comparable in all three of our F. dys. subjects, two with Arg145 -S Cys and one with Arg,58 --Cys. The reason for the apparent discrepancy between the equilibrium binding affinity and metabolic behavior of the two apo E-2 variants is unclear. Our results raise the possibility that endocytosis of remnants in vivo, which occurs under nonequilibrium conditions, may not be reflected by the affinity for the receptor at equilibrium. Alternatively, the conformation of the apo E in isolated lipoproteins may differ from its conformation in lipoproteins in the blood.
As in our normolipidemic subjects, apo B-48 ofchylomicrons and apo B-I00 of large VLDL were not converted appreciably to LDL in our F. dys. patients, despite long residence times of these proteins. Reduced conversion of remnant particles to LDL may explain the low LDL concentrations in F. dys. (37, 38) . Apo E may have a role in this conversion (4 (43) . Low LDL levels in F. dys. could also reflect increased LDL clearance due to upregulation ofthe LDL receptors (44) as a result of the impaired uptake of lipoprotein remnants, but the eventual site of uptake of lipoproteins that contain apo B-48 and B-I00 in this disorder remains to be determined.
